BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatr 2012; 2(5): 74-82 [PMID: 24175171 DOI: 10.5498/wjp.v2.i5.74]
URL: https://www.wjgnet.com/2220-3206/full/v2/i5/74.htm
Number Citing Articles
Emilie Leclerc, Cristiano Noto, Rodrigo A. Bressan, Elisa Brietzke. Determinants of adherence to treatment in first-episode psychosis: a comprehensive reviewRevista Brasileira de Psiquiatria 2015; 37(2): 168 doi: 10.1590/1516-4446-2014-1539
Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, Juan José Fernández-Miranda. Mirror image study (10 years of follow-up and 10 of standard pre-treatment) of psychiatric hospitalizations of patients with severe schizophrenia treated in a community-based, case-managed programmeRevista de Psiquiatría y Salud Mental (English Edition) 2022; 15(1): 47 doi: 10.1016/j.rpsmen.2022.01.002
Giulia M. Giordano, Francesco Brando, Pasquale Pezzella, Maria De Angelis, Armida Mucci, Silvana Galderisi. Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literatureFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.970210
Joyce Protas Mlay, Lise Jamieson, Vuyokazi Ntlantsana, Thirusha Naidu, Busisiwe Siphumelele Bhengu, Saeeda Paruk, Jonathan K Burns, Bonginkosi Chiliza, Richard Lessells, Andrew Tomita. Developing and testing unconditional cash transfer strategies among young adults with first-episode psychosis in South Africa: a study protocol for a pilot randomised control trial (PRS-FEP trial)BMJ Open 2022; 12(12): e067026 doi: 10.1136/bmjopen-2022-067026
Marwa Abdel-Rahman Sultan, Reem El Sayad Hashem, Nesreen Mohamed Mohsen, Doaa Helmy Barakat, Ramy Ali Ryad, Afaf Hamed Khalil. Studying medication adherence in patients with schizophreniaMiddle East Current Psychiatry 2016; 23(1): 27 doi: 10.1097/01.XME.0000475315.51718.d6
Christy Lai Ming Hui, Venessa Wing Yan Poon, Wai Tung Ko, Ho Yee Miao, Wing Chung Chang, Edwin Ho Ming Lee, Sherry Kit Wa Chan, Jingxia Lin, Eric Yu Hai Chen. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosisSchizophrenia Research 2016; 174(1-3): 144 doi: 10.1016/j.schres.2016.03.026
Tong Zhu. Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development—A Drug Developer's PerspectiveFrontiers in Psychiatry 2021; 11 doi: 10.3389/fpsyt.2020.562660
Dulcinea Vega, Francisco J Acosta, Pedro Saavedra. Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective studyWorld Journal of Psychiatry 2020; 10(11): 260-271 doi: 10.5498/wjp.v10.i11.260
Phoebe Wallman, Ivana Clark, David Taylor. Effect of 3-monthly paliperidone palmitate on hospitalisation in a naturalistic schizophrenia cohort – A five-year mirror image studyJournal of Psychiatric Research 2022; 148: 131 doi: 10.1016/j.jpsychires.2022.01.044
Ludovic Samalin, Ingrid de Chazeron, Raoul Belzeaux, Pierre-Michel Llorca, Michel Botbol. Exploratory analysis of the French version of the beliefs about medicines questionnaire in patients with severe mental disorders: Factorial structure and reliability in specific populations of schizophrenic, bipolar and depressive patientsPLOS ONE 2017; 12(3): e0173267 doi: 10.1371/journal.pone.0173267
Felice Iasevoli, Andrea Fagiolini, Maria Vittoria Formato, Emiliano Prinzivalli, Sara Giordano, Raffaele Balletta, Vincenzo De Luca, Andrea de Bartolomeis. Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patientsPsychiatry Research 2017; 249: 159 doi: 10.1016/j.psychres.2017.01.015
Karimah S. Bell Lynum, Ibrahim Turkoz, Edward Kim. Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophreniaEarly Intervention in Psychiatry 2019; 13(3): 667 doi: 10.1111/eip.12685
Meng Ji, Wenxiu Xie, Mengdan Zhao, Xiaobo Qian, Chi-Yin Chow, Kam-Yiu Lam, Jun Yan, Tianyong Hao, Deepika Koundal. Probabilistic Prediction of Nonadherence to Psychiatric Disorder Medication from Mental Health Forum Data: Developing and Validating Bayesian Machine Learning ClassifiersComputational Intelligence and Neuroscience 2022; 2022: 1 doi: 10.1155/2022/6722321
Cordellia E. Bright. Measuring Medication Adherence in Patients With Schizophrenia: An Integrative ReviewArchives of Psychiatric Nursing 2017; 31(1): 99 doi: 10.1016/j.apnu.2016.09.003
Ludovic Samalin, Ingrid de Chazeron, Olivier Blanc, Lore Brunel, Guillaume Fond, Pierre-Michel Llorca. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophreniaSchizophrenia Research 2016; 178(1-3): 1 doi: 10.1016/j.schres.2016.09.015
Arnold P. M. van der Lee, Ibrahim Önsesveren, André I. Wierdsma, Roos van Westrhenen, Aartjan T. F. Beekman, Lieuwe de Haan, Niels C. L. Mulder. The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort StudyCNS Drugs 2021;  doi: 10.1007/s40263-021-00802-3
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking projectRevista de Psiquiatría y Salud Mental (English Edition) 2017; 10(1): 4 doi: 10.1016/j.rpsmen.2016.09.002
S. Heres, M. Lambert, R. Vauth. Treatment of early episode in patients with schizophrenia: the role of long acting antipsychoticsEuropean Psychiatry 2014; 29(S2): 1409 doi: 10.1016/S0924-9338(14)70001-X
Maria João R.V. Martins, Ana Margarida Pinto, Paula Castilho, António F. Macedo, Ana Telma Pereira, Miguel Bajouco, Rita Leite, Ondina Matos, Sofia Morais, Nuno Madeira, Vasco Nogueira, Carolina Roque, Prazeres Santos, Telma Santos, Tiago Santos, Vítor Santos, Ana Filipa Troia, Célia Barreto-Carvalho. Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scalePsychiatry Research 2019; 273: 325 doi: 10.1016/j.psychres.2019.01.043
Lei Dou, Lili Hu, Nan Zhang, Henry Cutler, Yan Wang, Shunping Li. <p>Factors Associated with Medication Adherence Among Patients with Severe Mental Disorders in China: A Propensity Score Matching Study</p>Patient Preference and Adherence 2020; : 1329 doi: 10.2147/PPA.S255934
Meaghan Roach, Dee Lin, Marlon Graf, Priti Pednekar, Jacquelyn W Chou, Carmela Benson, Jalpa A Doshi. Schizophrenia population health management: perspectives of and lessons learned from population health decision makersJournal of Managed Care & Specialty Pharmacy 2021; 27(10-a Suppl): S2 doi: 10.18553/jmcp.2021.27.10-aa.s2
Amaury Lefebvre, Arnaud Pouchon, Stéphanie Bioulac, Jasmina Mallet, Mircea Polosan, Clément Dondé. Management of schizophrenia in women during the perinatal period: a synthesis of international recommendationsExpert Opinion on Pharmacotherapy 2022; 23(11): 1337 doi: 10.1080/14656566.2022.2102421
Saeed Farooq, Abid Choudry. Adherence to medication in the community: Audit cycle of interventions to improve the assessment of adherenceBJPsych Bulletin 2017; 41(1): 41 doi: 10.1192/pb.bp.115.053520
Zaina P. Qureshi, Rezaul Khandker, Jason Shepherd, Salome Samant, Farid Chekani, Hollie M. L. Bailey. Assessment of Real-Life Outcomes in Schizophrenia Patients according to CompliancePsychiatry Journal 2020; 2020: 1 doi: 10.1155/2020/5848601
Daisy Ng-Mak, Krithika Rajagopalan. Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measuresCurrent Medical Research and Opinion 2019; 35(1): 87 doi: 10.1080/03007995.2018.1532883
Jiansong Zhou, Yu-Tao Xiang, Qiguang Li, Xiaomin Zhu, Wen Li, Gabor S. Ungvari, Chee H. Ng, Dost Ongur, Xiaoping Wang. Gender differences in attitudes towards antipsychotic medications in patients with schizophreniaPsychiatry Research 2016; 245: 276 doi: 10.1016/j.psychres.2016.08.041
Yanling Zhou, Robert Rosenheck, Somaia Mohamed, Yuping Ning, Hongbo He. Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital dischargePsychiatry Research 2017; 250: 129 doi: 10.1016/j.psychres.2017.01.036
Marie Smith-East, Donna Felber Neff. Mental Health Care Access Using Geographic Information Systems: An Integrative ReviewIssues in Mental Health Nursing 2020; 41(2): 113 doi: 10.1080/01612840.2019.1646363
Susanne Jaeger, Carmen Pfiffner, Prisca Weiser, Gerhard Längle, Daniela Croissant, Wiltrud Schepp, Reinhold Kilian, Thomas Becker, Gerhard Eschweiler, Tilman Steinert. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercionSocial Psychiatry and Psychiatric Epidemiology 2013; 48(11): 1787 doi: 10.1007/s00127-013-0687-x
Maria Skott, Natalie Durbeej, Maria Smitmanis-Lyle, Clara Hellner, Emelie Allenius, Sigrid Salomonsson, Tobias Lundgren, Nitya Jayaram-Lindström, Alexander Rozental. Patient-controlled admissions to inpatient care: A twelve-month naturalistic study of patients with schizophrenia spectrum diagnoses and the effects on admissions to and days in inpatient careBMC Health Services Research 2021; 21(1) doi: 10.1186/s12913-021-06617-8
Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Lee. Delay in psychiatric hospitalization from the diagnosis of first-episode schizophrenia and its association with clinical outcomes and direct medical costs: a nationwide, health insurance data-based studyBMC Psychiatry 2022; 22(1) doi: 10.1186/s12888-022-04292-5
Gloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, Emanuela Amici, Filippo Perrini, Gemma Callovini, Alfonso Carannante, Georgios D. Kotzalidis, Sergio De Filippis. Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory AnalysisFrontiers in Psychiatry 2020; 10 doi: 10.3389/fpsyt.2019.00935
Yi Nam Suen, Emily Tsz Wa Yeung, Sherry Kit Wa Chan, Christy Lai Ming Hui, Edwin Ho Ming Lee, Wing Chung Chang, Candice Yu Hay Chan, Chan Eric Yu Hai Chen. Integration of biological and psychological illness attributional belief in association with medication adherence behaviour: A path analysisEarly Intervention in Psychiatry 2021; 15(6): 1686 doi: 10.1111/eip.13114
Isaac Tetteh Commey, Jerry Paul K. Ninnoni, Evelyn Asamoah Ampofo. Coping with personal care and stigma: experiences of persons living with schizophreniaBMC Nursing 2022; 21(1) doi: 10.1186/s12912-022-00891-5
Sung Woo Joo, Harin Kim, Young Tak Jo, Young Jae Choi, Soojin Ahn, Jungsun Lee. Antipsychotic treatment and risk of discontinuation and hospitalization in first-episode schizophrenia: a nationwide population-based studyPsychological Medicine 2021; : 1 doi: 10.1017/S0033291721001379
Jean-Michel Azorin, Nicolas Simon. Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationaleExpert Opinion on Drug Metabolism & Toxicology 2020; 16(12): 1175 doi: 10.1080/17425255.2020.1821646
Carlos Pérez-Ruixo, Bart Remmerie, Juan José Peréz-Ruixo, An Vermeulen. A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds—Application to Simulated Risperidone Data in Schizophrenic PatientsThe AAPS Journal 2019; 21(3) doi: 10.1208/s12248-019-0299-9
Oriana Bianchini, Stefano Porcelli, Claudia Nespeca, Dario Cannavò, Angela Trappoli, Eugenio Aguglia, Diana De Ronchi, Alessandro Serretti. Effects of antipsychotic drugs on insight in schizophreniaPsychiatry Research 2014; 218(1-2): 20 doi: 10.1016/j.psychres.2014.03.022
Claire Ainsworth. Assessing the robustness of direct meta-analysis in the presence of heterogeneityJournal of Comparative Effectiveness Research 2018; 7(10): 1009 doi: 10.2217/cer-2018-0024
Junpei Ishii, Fumitoshi Kodaka, Hisatsugu Miyata, Wataru Yamadera, Hikaru Seto, Hidejiro Higuchi, Yoshiaki Tsuruoka, Masahiro Shigeta. Association between functional recovery and medication adherence in schizophreniaNeuropsychopharmacology Reports 2022;  doi: 10.1002/npr2.12294
José Manuel Olivares, Ana González-Pinto, Mario Páramo. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational studyEuropean Psychiatry 2021; 64(1) doi: 10.1192/j.eurpsy.2021.23
G. Gozlan, L. Lecardeur, A.-S. Monfort, M. Doz, I. Ortiz, P. Larroumets, A. Lafuma. Analyse coût-efficacité de l’aripiprazole injectable à libération prolongée (AILP) comparé au palmitate de palipéridone (PP) dans le traitement de la schizophrénie en FranceL'Encéphale 2018; 44(6): 496 doi: 10.1016/j.encep.2018.10.001
Matt A. Brown, Ram J. Bishnoi, Sara Dholakia, Dawn I. Velligan. Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trialsExpert Review of Clinical Pharmacology 2016; 9(4): 591 doi: 10.1586/17512433.2016.1135734
Susanne Jaeger, Franziska Hüther, Tilman Steinert. Refusing Medication Therapy in Involuntary Inpatient Treatment—A Multiperspective Qualitative StudyFrontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00295
Hélène Verdoux, Clélia Quiles, Laura Bon, Isabelle Chéreau-Boudet, Julien Dubreucq, Emilie Legros-Lafarge, Nathalie Guillard-Bouhet, Catherine Massoubre, Julien Plasse, Nicolas Franck. Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centersEuropean Archives of Psychiatry and Clinical Neuroscience 2021; 271(8): 1415 doi: 10.1007/s00406-020-01207-x
Jamilla J Giles, Ivan Ling, Nigel McArdle, Romola S Bucks, Gemma Cadby, Bhajan Singh, Vera A Morgan, Laura Gabriel, Flavie Waters. Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic DisordersSchizophrenia Bulletin 2022; 48(2): 437 doi: 10.1093/schbul/sbab100
Claudio Brasso, Marta Cisotto, Camilla Ghirardini, Filippo Pennazio, Vincenzo Villari, Paola Rocca. Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency wardPsychiatry Research 2021; 305: 114214 doi: 10.1016/j.psychres.2021.114214
Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, Juan José Fernández-Miranda. Estudio en imagen en espejo (10 años de seguimiento y 10 de pretratamiento estándar) de ingresos hospitalarios de personas con esquizofrenia grave en un programa comunitario con gestión de casosRevista de Psiquiatría y Salud Mental 2022; 15(1): 47 doi: 10.1016/j.rpsm.2019.04.004
José Manuel Olivares, Andrea Fagiolini. Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly. Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled AnalysisFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.877867
Dulcinea Vega, Francisco J. Acosta, Pedro Saavedra. Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up studyComprehensive Psychiatry 2021; 108: 152240 doi: 10.1016/j.comppsych.2021.152240
Madeline Lim, Ziqiang Li, Huiting Xie, Bhing Leet Tan, Jimmy Lee. The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in SchizophreniaJournal of Clinical Psychopharmacology 2021; 41(5): 551 doi: 10.1097/JCP.0000000000001449
Bunta Yoshimura, Kojiro Sato, Manabu Takaki, Norihito Yamada. Algorithm-based pharmacotherapy for first-episode schizophrenia involuntarily hospitalized: A retrospective analysis of real-world practiceEarly Intervention in Psychiatry 2019; 13(1): 39 doi: 10.1111/eip.12442
Mogammad Shaheed Soeker, Tamarin Truter, Nicole Van Wilgen, Polly Khumalo, Heather Smith, Simone Bezuidenhout. The experiences and perceptions of individuals diagnosed with schizophrenia regarding the challenges they experience to employment and coping strategies used in the open labor market in Cape Town, South AfricaWork 2019; 62(2): 221 doi: 10.3233/WOR-192857
Charlotte Gary, Cécile Déal, Jennifer Boursicot‐Beuzelin, Bruno Falissard, Jean‐Yves Giordana, Eric Fakra, Ludovic Samalin, Sophie Bouju. Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross‐sectional OPTIMUS studyPharmacoepidemiology and Drug Safety 2022; 31(3): 334 doi: 10.1002/pds.5397
Sofia Brissos, David Taylor. Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?CNS Drugs 2022; 36(4): 315 doi: 10.1007/s40263-022-00906-4
N. Yalcin-Siedentopf, F. Wartelsteiner, A. Kaufmann, F. Biedermann, M. Edlinger, G. Kemmler, M. A. Rettenbacher, C. G. Widschwendter, G. Zernig, W. W. Fleischhacker, A. Hofer. Measuring Adherence to Medication in Schizophrenia: The Relationship between Attitudes toward Drug Therapy and Plasma Levels of New-Generation AntipsychoticsInternational Journal of Neuropsychopharmacology 2015; 18(5): pyu091 doi: 10.1093/ijnp/pyu091
Benedicto Crespo-Facorro, Miguel Bernardo, Josep Maria Argimon, Manuel Arrojo, Maria Fe Bravo-Ortiz, Ana Cabrera-Cifuentes, Julián Carretero-Román, Manuel A. Franco-Martín, Paz García-Portilla, Josep Maria Haro, José Manuel Olivares, Rafael Penadés, Javier del Pino-Montes, Julio Sanjuán, Celso Arango. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto RethinkingRevista de Psiquiatría y Salud Mental 2017; 10(1): 4 doi: 10.1016/j.rpsm.2016.09.001
Sangeeta Tanna, Graham Lawson. Analytical Chemistry for Assessing Medication Adherence2016; : 87 doi: 10.1016/B978-0-12-805463-5.00004-3
David DeWorsop, Gina Creatura, Grai Bluez, Halle Thurnauer, Kimberlee Forselius-Bielen, Mohini Ranganathan, Emma Deaso, Jasra Ali Bhat, Deepak Cyril D’Souza. Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trialsDrug and Alcohol Dependence 2016; 163: 24 doi: 10.1016/j.drugalcdep.2016.02.045
Meaghan Roach, Dee Lin, Marlon Graf, Priti Pednekar, Jacquelyn W Chou, Carmela Benson, Jalpa A Doshi. Schizophrenia population health management: perspectives of and lessons learned from population health decision makersJournal of Managed Care & Specialty Pharmacy 2021; 27(10-a Suppl): S1 doi: 10.18553/jmcp.2021.27.10-a.s1
Slawomir Murawiec, Aleksandra Rajewska-Rager, Jerzy Samochowiec, Sylwia Kalinowska, Jacek Kurpisz, Joanna Krzyzanowska, Halina Sienkiewicz-Jarosz, Iwona Kurkowska-Jastrzebska, Agnieszka Samochowiec, Przemyslaw Bienkowski. Pharmacy switch of antipsychotic medications: patient’s perspectiveAnnals of General Psychiatry 2015; 14(1) doi: 10.1186/s12991-015-0066-y
Giulia Cossu, Davide Gyppaz, Goce Kalcev, Anna Rafaela Manca, Matthias Angermeyer, Thurayya Zreik, Mauro G. Carta. Systematic review of involuntary hospitalisation and long-term complianceInternational Review of Psychiatry 2022; : 1 doi: 10.1080/09540261.2022.2119074
Christian G. Widschwendter, Georg Kemmler, Maria A. Rettenbacher, Nursen Yalcin-Siedentopf, Alex Hofer. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medicationBMC Psychiatry 2018; 18(1) doi: 10.1186/s12888-018-1791-y
Letícia P. Tergolina, Airton T. Stein, Evelise R. de Faria. Adherence to treatment in collective multiprofessional activities and factors associated with adherence in a specialized center for psychosocial careTrends in Psychiatry and Psychotherapy 2020; 42(4): 329 doi: 10.1590/2237-6089-2019-0053
Rama Melkote, Arun Singh, An Vermeulen, Bart Remmerie, Adam Savitz. Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studySchizophrenia Research 2018; 201: 324 doi: 10.1016/j.schres.2018.05.028
Luis Eduardo Jaramillo González, Carlos Gómez Restrepo, Jenny García Valencia, Ana María de la Hoz Bradford, Mauricio Ávila-Guerra, Adriana Bohórquez Peñaranda. Tratamiento con antipsicóticos de depósito del paciente adulto con diagnóstico de esquizofreniaRevista Colombiana de Psiquiatría 2014; 44: 40 doi: 10.1016/j.rcp.2015.05.005
Anirban Basu, Carmela Benson, Larry Alphs. Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with SchizophreniaJournal of Managed Care & Specialty Pharmacy 2018; 24(8): 759 doi: 10.18553/jmcp.2018.24.8.759
Tadele Eticha, Amha Teklu, Dagim Ali, Gebremedhin Solomon, Adissu Alemayehu, Jerson Laks. Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern EthiopiaPLOS ONE 2015; 10(3): e0120560 doi: 10.1371/journal.pone.0120560
P.M. Ljungdalh. Non-adherence to pharmacological treatment in schizophrenia and schizophrenia spectrum disorders – An updated systematic literature reviewThe European Journal of Psychiatry 2017; 31(4): 172 doi: 10.1016/j.ejpsy.2017.08.001
Stacy Ellenberg, Brandon A. Gaudiano. Behavior Therapy2022; : 505 doi: 10.1007/978-3-031-11677-3_22
Christy Lai-Ming Hui, Venessa Wing-Yan Poon, Vivian Shuk-Kuen Kwok, Wing-Chung Chang, Sherry Kit-Wa Chan, Edwin Ho-Ming Lee, Eric Yu-Hai Chen. Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosisPsychiatry Research 2015; 228(3): 680 doi: 10.1016/j.psychres.2015.04.047
Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima, Sakiko Yamada. Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in JapanAdvances in Therapy 2020; 37(7): 3324 doi: 10.1007/s12325-020-01396-w
Alexander Keenan, Dee Lin, Jason Shepherd, Hollie Bailey, Carmela Benson, Sophie Meakin. Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time surveyBMC Psychiatry 2022; 22(1) doi: 10.1186/s12888-022-03846-x
Warut Aunjitsakul, Teerapat Teetharatkul, Arnont Vitayanont, Tippawan Liabsuetrakul. Does the Psychiatrist’s Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient’s Well-Being Perception than Clinical Judgement Alone?Administration and Policy in Mental Health and Mental Health Services Research 2021; 48(5): 768 doi: 10.1007/s10488-021-01127-5
Päivi Soininen, Hanna Putkonen, Grigori Joffe, Jyrki Korkeila, Pauli Puukka, Anneli Pitkänen, Maritta Välimäki. Does experienced seclusion or restraint affect psychiatric patients’ subjective quality of life at discharge?International Journal of Mental Health Systems 2013; 7(1) doi: 10.1186/1752-4458-7-28
Shi Hyun Kang, Hey Won Lee. Attitude Toward Illness and Treatment in Adherent Schizophrenia Patients: A Qualitative StudyJournal of Korean Neuropsychiatric Association 2020; 59(2): 159 doi: 10.4306/jknpa.2020.59.2.159
Rohan Mahabaleshwarkar, Dee Lin, Jesse Fishman, Todd Blair, Timothy Hetherington, Pooja Palmer, Charmi Patel, Carmela Benson, Kruti Joshi, Constance Krull, Oleg V. Tcheremissine. The Impact of Once-Monthly Paliperidone Palmitate on Healthcare Utilization Among Patients With Schizophrenia Treated in an Integrated Healthcare System: A Retrospective Mirror-Image StudyAdvances in Therapy 2021; 38(4): 1958 doi: 10.1007/s12325-021-01626-9
S.M.Y. Arafat, B. Mali, H. Akter. Proportion and reasons for medication non-compliance among schizophrenics: A cross-sectional observation in a tertiary care hospital of BangladeshAsian Journal of Psychiatry 2018; 35: 52 doi: 10.1016/j.ajp.2018.05.005
David Fraguas, David Almenta Gallego, Sergio Arques-Egea, Marcos Gómez-Revuelta, Carlos Gómez Sánchez-Lafuente, Daniel Hernández Huerta, Daniel Núñez Arias, Beatriz Oda Plasencia-García, Carlos Parro Torres, Samuel Leopoldo Romero-Guillena, Elena Ros Cucurul, Cecilio Alamo. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceInternational Journal of Psychiatry in Clinical Practice 2022; : 1 doi: 10.1080/13651501.2022.2064308
Matt Shirley, Caroline M. Perry. Aripiprazole (ABILIFY MAINTENA®): A Review of Its Use as Maintenance Treatment for Adult Patients with SchizophreniaDrugs 2014; 74(10): 1097 doi: 10.1007/s40265-014-0231-7
E. Chui, K.L. Wong, K.Y. Chan, M. Wong. Validation study of the Brief Medication Adherence Scale (BMAS) in patients with schizophrenia and related disorders in Hong KongAsian Journal of Psychiatry 2018; 37: 154 doi: 10.1016/j.ajp.2018.09.005
Noraly Stam, Heidi Taipale, Antti Tanskanen, Luka Isphording, Cynthia Okhuijsen‐Pfeifer, Catharina C.M. Schuiling‐Veninga, Jens H.J. Bos, Bert J. Bijker, Jari Tiihonen, Jurjen J. Luykx. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real‐World Study Across AntipsychoticsClinical and Translational Science 2020; 13(6): 1170 doi: 10.1111/cts.12801
Nuray A Karanci, Aylin Aras, Guler Beril Kumpasoğlu, Demet Can, Ekin Çakır, Cemrenur Karaaslan, Mine Semerci, Duygu Tüzün. Living with schizophrenia: Perspectives of Turkish people with schizophrenia from two Patient Associations on how the illness affects their livesInternational Journal of Social Psychiatry 2019; 65(2): 98 doi: 10.1177/0020764018820879
Hong Kyu Ihm, Sang Hoon Kim, Jung Ho Kim, Kang Su Ha, Hyun Park. Factors Related to Medication Adherence in Outpatients with Schizophrenia under More Than 5 Years of TreatmentJournal of Korean Neuropsychiatric Association 2016; 55(4): 397 doi: 10.4306/jknpa.2016.55.4.397
Aikaterini Garbi, Ioannis Tiniakos, Zacharenia Mikelatou, Ioannis Drakatos. Decrease of Hospitalizations and Length of Hospital Stay in Patients with Schizophrenia Spectrum Disorders or Bipolar Disorder Treated in a Mobile Mental Health Service in Insular GreecePsych 2021; 3(4): 780 doi: 10.3390/psych3040049
Frank E. Zongo, Jocelyne Moisan, Jean-Pierre Grégoire, Alain Lesage, Anara Richi Dossa, Sophie Lauzier. Association between community pharmacy loyalty and persistence and implementation of antipsychotic treatment among individuals with schizophreniaResearch in Social and Administrative Pharmacy 2018; 14(1): 53 doi: 10.1016/j.sapharm.2016.12.006
Xiao-Qin Wang, Marcia Petrini, Donald E. Morisky. Comparison of the Quality of Life, Perceived Stigma and Medication Adherence of Chinese with Schizophrenia: A Follow-Up StudyArchives of Psychiatric Nursing 2016; 30(1): 41 doi: 10.1016/j.apnu.2015.10.006
Andrea Aguglia, Laura Fusar-Poli, Antimo Natale, Andrea Amerio, Irene Espa, Veronica Villa, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D’Agostino, Gianluca Serafini, Mario Amore, Eugenio Aguglia, Giovanni Ostuzzi, Corrado Barbui. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot StudyPharmacopsychiatry 2022; 55(06): 281 doi: 10.1055/a-1804-6211
Hsue-Wei Chan, Chin-Yu Huang, Wen-Jui Feng, Yung-Chieh Yen. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort studyPsychiatry and Clinical Neurosciences 2015; 69(8): 497 doi: 10.1111/pcn.12294
Subho Chakrabarti. What&rsquo;s in a name? Compliance, adherence and concordance in chronic psychiatric disordersWorld Journal of Psychiatry 2014; 4(2): 30-36 doi: 10.5498/wjp.v4.i2.30
Marwa A. El Meguid, Heba Eissawy, Walaa Sabry, Mostafa Bastawy, Doaa Khalifa, Ramy Ali. Understanding medication nonadherence in a sample of Egyptian patients with schizophrenia in relation to illness severity and insightMiddle East Current Psychiatry 2016; 23(4): 161 doi: 10.1097/01.XME.0000499561.13974.8c
Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Lee. One-Year Clinical Outcomes Following Electroconvulsive Therapy for Patients with Schizophrenia: A Nationwide Health Insurance Data-Based StudyNeuropsychiatric Disease and Treatment 2022; : 1645 doi: 10.2147/NDT.S373222
Sandra I. Ralat, Colin A. Depp, Guillermo Bernal. Reasons for Nonadherence to Psychiatric Medication and Cardiovascular Risk Factors Treatment Among Latino Bipolar Disorder Patients Living in Puerto Rico: A Qualitative StudyCommunity Mental Health Journal 2018; 54(6): 707 doi: 10.1007/s10597-017-0202-z